(Q34639820)

3 August 2017

1 reference

title

Prognostic factors in breast cancer: current and new predictors of metastasis (English)

1 reference

3 August 2017

1 reference

Hayes DF

1

1 reference

3 August 2017

Isaacs C

series ordinal

2

1 reference

3 August 2017

Stearns V

series ordinal

3

1 reference

3 August 2017

1 October 2001

1 reference

Journal of Mammary Gland Biology and Neoplasia

3 August 2017

1 reference

3 August 2017

6

1 reference

3 August 2017

4

1 reference

3 August 2017

375-392

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1014778713034

3 August 2017

0 references

cites work

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

1 reference

12 December 2020

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

1 reference

12 December 2020

Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study

1 reference

12 December 2020

Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a Cancer and Leukemia Group B correlative science study from protocols 8541/8869.

1 reference

12 December 2020

Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer

1 reference

12 December 2020

Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis

1 reference

12 December 2020

Sentinel lymphadenectomy in breast cancer

1 reference

12 December 2020

Osteopontin expression in a group of lymph node negative breast cancer patients

1 reference

12 December 2020

Prognostic variables in node-negative and node-positive breast cancer

1 reference

12 December 2020

Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up

1 reference

12 December 2020

The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy

1 reference

12 December 2020

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

12 December 2020

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

1 reference

12 December 2020

Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer

1 reference

12 December 2020

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

12 December 2020

High levels of TIMP-2 correlate with adverse prognosis in breast cancer.

1 reference

12 December 2020

Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin

1 reference

12 December 2020

INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis

1 reference

12 December 2020

Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated

1 reference

12 December 2020

Cyclin D1 and prognosis in human breast cancer.

1 reference

12 December 2020

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

1 reference

12 December 2020

Breast cancer prognostic factors: evaluation guidelines.

1 reference

12 December 2020

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

1 reference

12 December 2020

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

1 reference

12 December 2020

New prognostic factors for breast cancer recurrence

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.

1 reference

12 December 2020

Clinical significance of determination of surrogate markers of angiogenesis in breast cancer

1 reference

12 December 2020

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

1 reference

12 December 2020

Immunohistologic evaluation of invasion-associated proteases in breast carcinoma

1 reference

12 December 2020

Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up

1 reference

12 December 2020

Status of breast cancer prognostication based on histopathologic data.

1 reference

12 December 2020

I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

1 reference

12 December 2020

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

1 reference

12 December 2020

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

12 December 2020

Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.

1 reference

12 December 2020

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?

1 reference

12 December 2020

Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

12 December 2020

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years

1 reference

12 December 2020

Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer

1 reference

12 December 2020

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

1 reference

12 December 2020

Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration

1 reference

12 December 2020

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

12 December 2020

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

1 reference

12 December 2020

Individual characterisation of the metastatic capacity of human breast carcinoma

1 reference

12 December 2020

Bcl-2 and the regulation of programmed cell death

1 reference

12 December 2020

DNA methylation in breast cancer

1 reference

12 December 2020

Prognostic and predictive value of thymidine labelling index in breast cancer

1 reference

12 December 2020

Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials

1 reference

12 December 2020

American Joint Committee on Cancer prognostic factors consensus conference

1 reference

12 December 2020

Statistical aspects of prognostic factor studies in oncology

1 reference

12 December 2020

Cyclin D1 in breast cancer

1 reference

12 December 2020

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Detection and Significance of Occult Axillary Metastatic Disease in Breast Cancer Patients

1 reference

12 December 2020

Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement

1 reference

12 December 2020

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

Time-dependence of hazard ratios for prognostic factors in primary breast cancer

1 reference

12 December 2020

The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer

1 reference

12 December 2020

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

12 December 2020

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

12 December 2020

Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.

1 reference

12 December 2020

The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer.

1 reference

12 December 2020

Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group

1 reference

12 December 2020

Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases

1 reference

12 December 2020

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

12 December 2020

Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

S-phase fraction and breast cancer--a decade of experience

1 reference

12 December 2020

Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

12 December 2020

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients

1 reference

12 December 2020

Cathepsin D and breast cancer

1 reference

12 December 2020

Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer

1 reference

12 December 2020

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology

1 reference

12 December 2020

Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patients

1 reference

12 December 2020

The sentinel node in breast cancer--a multicenter validation study

1 reference

12 December 2020

Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.

1 reference

12 December 2020

Methodological challenges in the evaluation of prognostic factors in breast cancer

1 reference

12 December 2020

Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining

1 reference

12 December 2020

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

1 reference

12 December 2020

How to use prognostic factors in axillary node-negative breast cancer patients

1 reference

12 December 2020

Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma

1 reference

12 December 2020

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

1 reference

12 December 2020

When and to what end do pathologists agree?

1 reference

12 December 2020

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

1 reference

12 December 2020

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1014778713034

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference